webinar register page

Building Vaccine Confidence for COVID-19 Vaccines in Adolescents
The U.S. Food and Drug Administration expanded the emergency use authorization (EUA) for the Pfizer-BioNTech COVID-19 Vaccine for the prevention of coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) to include adolescents 12 through 15 years of age.

During this webinar, Pfizer will provide vaccine confidence overview, discuss the importance of COVID-19 vaccination in adolescents, review Pfizer BioNTech adolescent clinical trial data for ages 12-15, and provide Pfizer-BioNTech COVID-19 storage and handling updates.

Please note: this webinar will NOT be recorded. Only registered participants will be able to join.

Jun 22, 2021 03:00 PM in Eastern Time (US and Canada)

Webinar is over, you cannot register now. If you have any questions, please contact Webinar host: NACCHO Preparedness.